To further determine whether YAP1-regulated genes are associated with poor prognosis, we analyzed YAP1 downstream genes, including AMOTL2, CYR61, CTGF, MYC, AREG, GLI2, and AXL [8], in different prognosis groups of IBC patients from The Cancer Genome Talas (TCGA) dataset (n = 962) based on the SurExpress program. This evidence concerns the gene AMOTL2 and inflammatory breast carcinoma.